|
MAN2A1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.27915472553286E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.29690000352889E-09 |
| Normal-vs-Stage2 |
1.86630000009735E-07 |
| Normal-vs-Stage3 |
1.06659999721259E-08 |
| Normal-vs-Stage4 |
4.42419999524546E-08 |
| Stage1-vs-Stage2 |
4.603400E-01 |
| Stage1-vs-Stage3 |
1.912840E-01 |
| Stage1-vs-Stage4 |
2.549400E-01 |
| Stage2-vs-Stage3 |
8.180800E-01 |
| Stage2-vs-Stage4 |
7.245400E-01 |
| Stage3-vs-Stage4 |
8.779600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.64810054492648E-10 |
| Normal-vs-AfricanAmerican |
1.457000E-03 |
| Normal-vs-Asian |
1.25839999531863E-08 |
| Caucasian-vs-AfricanAmerican |
5.232200E-01 |
| Caucasian-vs-Asian |
1.458190E-01 |
| AfricanAmerican-vs-Asian |
1.180750E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.73960001959017E-09 |
| Normal-vs-Female |
3.70029999974264E-08 |
| Male-vs-Female |
3.906200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.36480000026518E-07 |
| Normal-vs-Age(41-60Yrs) |
2.76169997981413E-09 |
| Normal-vs-Age(61-80Yrs) |
8.17129996999455E-09 |
| Normal-vs-Age(81-100Yrs) |
1.144000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.749800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.763800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.566000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.859400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.767200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.879800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.645400E-01 |
| Classical-VS-Follicular |
3.393200E-01 |
| Classical-VS-Other |
2.918000E-01 |
| Classical-VS-Normal |
1.56020000030566E-07 |
| Tall-VS-Follicular |
9.251800E-01 |
| Tall-VS-Other |
5.278400E-01 |
| Tall-VS-Normal |
2.13369999999546E-05 |
| Follicular-VS-Other |
4.996400E-01 |
| Follicular-VS-Normal |
2.35649999513754E-08 |
| Other-VS-Normal |
2.980900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.91040000380372E-09 |
| Normal-vs-N1 |
3.33449999834201E-08 |
| N0-vs-N1 |
6.854800E-01 |
|
|
